Role of acetylation in doxorubicin-induced cardiotoxicity
As a potent chemotherapeutic agent, doxorubicin (DOX) is widely used for the treatment of a variety of cancers However, its clinical utility is limited by dose-dependent cardiotoxicity, and pathogenesis has traditionally been attributed to the formation of reactive oxygen species (ROS). Accordingly,...
Main Authors: | Daisong Li, Yanyan Yang, Shizhong Wang, Xiangqin He, Meixin Liu, Baochen Bai, Chao Tian, Ruicong Sun, Tao Yu, Xianming Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231721002482 |
Similar Items
-
Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro
by: Wang Wen-Ching, et al.
Published: (2012-08-01) -
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
by: Maria Isabel Camara Planek, et al.
Published: (2020-07-01) -
Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
by: Himani Kumari, et al.
Published: (2020-05-01) -
Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats
by: Yan-Yan Zhang, et al.
Published: (2017-09-01) -
Advances of MicroRNA in the diagnosis and mechanism of doxorubicin-induced cardiotoxicity
by: Yi-Xin Su, et al.
Published: (2021-01-01)